Juvise

Juvisé Pharmaceuticals acquires multiple sclerosis drug PONVORY® (ex-US/Canada) and opens its capital to Bpifrance and Pemberton

Posted on 26 March 2024 by enano-tech-2

Juvisé Pharmaceuticals successfully completes a €400M refinancing following the acquisition of the worldwide rights of Pylera®

Posted on 3 March 20233 March 2023 by enano-tech-2

Interview of Frédéric Mascha, Founder and President of Juvisé Pharmaceuticals, by the French economic journalist, Nicolas Doze, on BFM Business channel

Posted on 14 December 20208 February 2022 by enano-tech-2

For the replay (in French), go to: https://www.bfmtv.com/economie/replay-emissions/hashtag-jmleco/juvise-pharmaceuticals-un-acteur-atypique-dans-le-monde-de-la-pharmacie_AV-202012140119.html

Juvisé Pharmaceuticals successfully syndicated its EUR 213 million financing in less than one month

Posted on 4 February 202021 July 2022 by Rochdi

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed id felis luctus, venenatis dolor non, sagittis leo. Nulla a suscipit elit, ut tempor nunc. Suspendisse accumsan nibh eget velit sodales condimentum.

The French speciality pharmaceutical company, Juvisé Pharmaceuticals acquires two oncology products from AstraZeneca

Posted on 20 December 201921 July 2022 by Rochdi

Contact Juvisé Pharmaceuticals

Contact

This site is registered on wpml.org as a development site.